相似文献
1
[The progresses in research and treatment of inherited platelet disorders].
Zhonghua Xue Ye Xue Za Zhi. 2018 Oct 14;39(10):877-880. doi: 10.3760/cma.j.issn.0253-2727.2018.10.019.
2
Inherited platelet disorders.
J Vet Emerg Crit Care (San Antonio). 2012 Feb;22(1):30-41. doi: 10.1111/j.1476-4431.2011.00702.x. Epub 2012 Jan 13.
3
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders.
Haematologica. 2017 Jul;102(7):1192-1203. doi: 10.3324/haematol.2016.160754. Epub 2017 Apr 6.
4
Inherited Platelet Disorders: Diagnosis and Management.
Transfus Med Rev. 2020 Oct;34(4):277-285. doi: 10.1016/j.tmrv.2020.09.006. Epub 2020 Sep 19.
5
Inherited Platelet Disorders: A Modern Approach to Evaluation and Treatment.
Hematol Oncol Clin North Am. 2019 Jun;33(3):471-487. doi: 10.1016/j.hoc.2019.01.008. Epub 2019 Apr 2.
6
Spectrum of Von Willebrand disease and inherited platelet function disorders amongst Indian bleeders.
Ann Hematol. 2007 Jun;86(6):403-7. doi: 10.1007/s00277-006-0244-8. Epub 2007 Mar 21.
7
Use of ISTH bleeding assessment tool to predict inherited platelet dysfunction in resource constrained settings.
Scand J Clin Lab Invest. 2016 Sep;76(5):373-8. doi: 10.1080/00365513.2016.1183260. Epub 2016 May 23.
8
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders.
Expert Rev Hematol. 2023 Mar;16(sup1):39-54. doi: 10.1080/17474086.2023.2171983.
9
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology.
J Thromb Haemost. 2021 May;19(5):1364-1371. doi: 10.1111/jth.15263.
10
Genetics of inherited platelet disorders.
Hamostaseologie. 2014;34(2):133-41. doi: 10.5482/HAMO-13-09-0049. Epub 2013 Dec 19.
本文引用的文献
1
Current and future antiplatelet therapies: emphasis on preserving haemostasis.
Nat Rev Cardiol. 2018 Mar;15(3):181-191. doi: 10.1038/nrcardio.2017.206. Epub 2018 Jan 3.
2
RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM).
Semin Hematol. 2017 Apr;54(2):75-80. doi: 10.1053/j.seminhematol.2017.04.006. Epub 2017 Apr 13.
3
A novel nonsense NBEAL2 gene mutation causing severe bleeding in a patient with gray platelet syndrome.
Platelets. 2018 May;29(3):288-291. doi: 10.1080/09537104.2017.1306041. Epub 2017 May 15.
4
Cangrelor: A New Route for P2Y12 Inhibition.
Cardiol Rev. 2017 May/Jun;25(3):133-139. doi: 10.1097/CRD.0000000000000142.
5
Modeling Glanzmann thrombasthenia using patient specific iPSCs and restoring platelet aggregation function by CD41 overexpression.
Stem Cell Res. 2017 Apr;20:14-20. doi: 10.1016/j.scr.2017.02.003. Epub 2017 Feb 11.
6
NGS-based 100-gene panel of hypopigmentation identifies mutations in Chinese Hermansky-Pudlak syndrome patients.
Pigment Cell Melanoma Res. 2016 Nov;29(6):702-706. doi: 10.1111/pcmr.12534. Epub 2016 Oct 19.
7
Genomics of platelet disorders.
Haemophilia. 2016 Jul;22 Suppl 5:20-4. doi: 10.1111/hae.12964.
8
Should any genetic defect affecting α-granules in platelets be classified as gray platelet syndrome?
Am J Hematol. 2016 Jul;91(7):714-8. doi: 10.1002/ajh.24359. Epub 2016 Apr 26.
9
Platelet functional alterations in a Bernard-Soulier syndrome patient with filamin A mutation.
J Hematol Oncol. 2015 Jul 2;8:79. doi: 10.1186/s13045-015-0171-z.
10
Deleterious mutation in the FYB gene is associated with congenital autosomal recessive small-platelet thrombocytopenia.
J Thromb Haemost. 2015 Jul;13(7):1285-92. doi: 10.1111/jth.12966. Epub 2015 May 25.
Zotero 插件